MiR-16-1 promotes the aberrant α -synuclein accumulation in parkinson disease via targeting heat shock protein 70

Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Zhang, Zhelin ^a,b   Cheng, Yan ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b INNER MONGOLIA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; HEAT SHOCK PROTEIN 70; MICRORNA 16; MICRORNA; MIRN16 MICRORNA, HUMAN; SNCA PROTEIN, HUMAN;

ARTICLE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; NEUROBLASTOMA CELL LINE; PARKINSON DISEASE; PROTEIN AGGREGATION; PROTEIN TARGETING; RECEPTOR DOWN REGULATION; RNA ISOLATION; DOWN REGULATION; GENETICS; METABOLISM; PROTEINOSIS; TUMOR CELL LINE;

ALPHA-SYNUCLEIN; CELL LINE, TUMOR; DOWN-REGULATION; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MICRORNAS; PARKINSON DISEASE; PROTEIN AGGREGATION, PATHOLOGICAL;

EID: 84904130683     PISSN: 23566140     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/938348     Document Type: Article

References (34)

1. Bertram L., Tanzi R. E., The genetic epidemiology of neurodegenerative disease. The Journal of Clinical Investigation 2005 115 6 1449 1457 10.1172/JCI24761 2-s2.0-20444504698 (Pubitemid 40814649)
2. Wirdefeldt K., Adami H., Cole P., Trichopoulos D., Mandel J., Epidemiology and etiology of Parkinson's disease: a review of the evidence. European Journal of Epidemiology 2011 26 1, supplement S1 S58 10.1007/s10654-011-9581-6 2-s2.0-79959728747
3. Irizarry M. C., Growdon W., Gomez-Isla T., Newell K., George J. M., Clayton D. F., Hyman B. T., Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α -synuclein immunoreactivity. Journal of Neuropathology and Experimental Neurology 1998 57 4 334 337 10.1097/00005072-199804000-00005 2-s2.0-0031944830 (Pubitemid 28182631)
4. Spillantini M. G., Crowther R. A., Jakes R., Hasegawa M., Goedert M., α -Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proceedings of the National Academy of Sciences of the United States of America 1998 95 11 6469 6473 10.1073/pnas.95.11.6469 2-s2.0-0032568534 (Pubitemid 28249037)
5. Krüger R., Kuhn W., Müller T., Woitalla D., Graeber M., Kösel S., Przuntek H., Epplen J. T., Schöls L., Riess O., Ala30Pro mutation in the gene encoding α -synuclein in Parkinson's disease. Nature Genetics 1998 18 2 106 108 10.1038/ng0298-106 2-s2.0-0031990490
6. Chartier-Harlin M., Kachergus J., Roumier C., Mouroux V., Douay X., Lincoln S., Levecque C., Larvor L., Andrieux J., Hulihan M., Waucquier N., Defebvre L., Amouyel P., Farrer M., Destée A., α -synuclein locus duplication as a cause of familial Parkinson's disease. The Lancet 2004 364 9440 1167 1169 10.1016/S0140-6736(04)17103-1 2-s2.0-4644290985 (Pubitemid 39296604)
7. Kahle P. J., α -Synucleinopathy models and human neuropathology: similarities and differences. Acta Neuropathologica 2008 115 1 87 95 10.1007/s00401-007-0302-x 2-s2.0-36949031267 (Pubitemid 350238669)
8. Kholodilov N. G., Neystat M., Oo T. F., Lo S. E., Larsen K. E., Sulzer D., Burke R. E., Increased expression of rat synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury. Journal of Neurochemistry 1999 73 6 2586 2599 10.1046/j.1471-4159.1999.0732586.x 2-s2.0-0032707654
9. George J. M., Jin H., Woods W. S., Clayton D. F., Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 1995 15 2 361 372 10.1016/0896-6273(95)90040-3 2-s2.0-0029127954
10. Periquet M., Fulga T., Myllykangas L., Schlossmacher M. G., Feany M. B., Aggregated α -synuclein mediates dopaminergic neurotoxicity in vivo. Journal of Neuroscience 2007 27 12 3338 3346 10.1523/JNEUROSCI.0285-07.2007 2-s2.0-33947505619 (Pubitemid 46474139)
11. Auluck P. K., Chan H. Y. E., Trojanowski J. Q., Lee V. M., Bonini N. M., Chaperone suppression of α -synuclein toxicity in a Drosophila model for Parkinson's disease. Science 2002 295 5556 865 868 10.1126/science.1067389 2-s2.0-0036468432 (Pubitemid 34118369)
12. Klucken J., Shin Y., Masliah E., Hyman B. T., McLean P. J., Hsp70 reduces α -synuclein aggregation and toxicity. The Journal of Biological Chemistry 2004 279 24 25497 25502 10.1074/jbc.M400255200 2-s2.0-2942620074 (Pubitemid 38756808)
13. Luk K. C., Mills I. P., Trojanowski J. Q., Lee V. M., Interactions between Hsp70 and the hydrophobic core of α -synuclein inhibit fibril assembly. Biochemistry 2008 47 47 12614 12625 10.1021/bi801475r 2-s2.0-56749117866
14. Ambros V., MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 2003 113 6 673 676 10.1016/S0092-8674(03)00428-8 2-s2.0-0038343499 (Pubitemid 36724931)
15. Reinhart B. J., Slack F. J., Basson M., Pasquienelll A. E., Bettlnger J. C., Rougvle A. E., Horvitz H. R., Ruvkun G., The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000 403 6772 901 906 10.1038/35002607 2-s2.0-0034708122 (Pubitemid 30130993)
16. Kosik K. S., The neuronal microRNA system. Nature Reviews Neuroscience 2006 7 12 911 920 10.1038/nrn2037 2-s2.0-33751254116 (Pubitemid 44780721)
17. Miska E. A., Alvarez-Saavedra E., Townsend M., Yoshii A., Sestan N., Rakic P., Constantine-Paton M., Horvitz H. R., Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biology 2004 5 9 R68 10.1186/gb-2004-5-9-r68 2-s2.0-5344273958
18. Hébert S. S., Horré K., Nicolaï L., Papadopoulou A. S., Mandemakers W., Silahtaroglu A. N., Kauppinen S., Delacourte A., De Strooper B., Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/ β -secretase expression. Proceedings of the National Academy of Sciences of the United States of America 2008 105 17 6415 6420 10.1073/pnas.0710263105 2-s2.0-44049108170 (Pubitemid 351758360)
19. Lee Y., Samaco R. C., Gatchel J. R., Thaller C., Orr H. T., Zoghbi H. Y., miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nature Neuroscience 2008 11 10 1137 1139 10.1038/nn.2183 2-s2.0-52949137369
20. Packer A. N., Xing Y., Harper S. Q., Jones L., Davidson B. L., The bifunctional microRNA miR-9/miR-9 regulates REST and CoREST and is downregulated in Huntington's disease. Journal of Neuroscience 2008 28 53 14341 14346 10.1523/JNEUROSCI.2390-08.2008 2-s2.0-58149375393
21. Kim J., Inoue K., Ishii J., Vanti W. B., Voronov S. V., Murchison E., Hannon G., Abeliovich A., A microRNA feedback circuit in midbrain dopamine neurons. Science 2007 317 5842 1220 1224 10.1126/science.1140481 2-s2.0-34548537573
22. Junn E., Lee K.-W., Jeong B.S., Chan T. W., Im J.-Y., Mouradian M. M., Repression of α -synuclein expression and toxicity by microRNA-7. Proceedings of the National Academy of Sciences of the United States of America 2009 106 31 13052 13057 10.1073/pnas.0906277106 2-s2.0-69149102628
23. Fewell S. W., Smith C. M., Lyon M. A., Dumitrescu T. P., Wipf P., Day B. W., Brodsky J. L., Small molecule modulators of endogenous and co-chaperone-stimulated Hsp70 ATPase activity. The Journal of Biological Chemistry 2004 279 49 51131 51140 10.1074/jbc.M404857200 2-s2.0-10944263745 (Pubitemid 40017855)
24. -ΔΔCT method. Methods 2001 25 4 402 408 10.1006/meth.2001.1262 2-s2.0-0035710746 (Pubitemid 34164012)
25. Gupta A., Dawson V. L., Dawson T. M., What causes cell death in Parkinson's disease? Annals of Neurology 2008 64 supplement 2 S3 S15 10.1002/ana.21573 2-s2.0-58349085737
26. Jellinger K. A., Basic mechanisms of neurodegeneration: a critical update. Journal of Cellular and Molecular Medicine 2010 14 3 457 487 10.1111/j.1582-4934.2010.01010.x 2-s2.0-77953417539
27. Hartl F. U., Hayer-Hartl M., Converging concepts of protein folding in vitro and in vivo. Nature Structural and Molecular Biology 2009 16 6 574 581 10.1038/nsmb.1591 2-s2.0-66849143696
28. Bandopadhyay R., de Belleroche J., Pathogenesis of Parkinson's disease: emerging role of molecular chaperones. Trends in Molecular Medicine 2010 16 1 27 36 10.1016/j.molmed.2009.11.004 2-s2.0-73649130269
29. Witt S. N., Hsp70 molecular chaperons and Parkinson's disease. Biopolymers 2010 93 3 218 228 10.1002/bip.21302 2-s2.0-75149142186
30. Cho H. J., Liu G., Jin S. M., Parisiadou L., Xie C., Yu J., Sun L., Ma B., Ding J., Vancraenenbroeck R., Lobbestael E., Baekelandt V., Taymans J., He P., Troncoso J. C., Shen Y., Cai H., Microrna-205 regulates the expression of parkinson's disease-related leucine-rich repeat kinase 2 protein. Human Molecular Genetics 2013 22 3 608 620 10.1093/hmg/dds470 2-s2.0-84872394361
31. Miñones-Moyano E., Porta S., Escaramís G., Rabionet R., Iraola S., Kagerbauer B., Espinosa-Parrilla Y., Ferrer I., Estivill X., Martí E., MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Human Molecular Genetics 2011 20 15 3067 3078 10.1093/hmg/ddr210 2-s2.0-79960135400
32. Asikainen S., Rudgalvyte M., Heikkinen L., Louhiranta K., Lakso M., Wong G., Nass R., Global microRNA expression profiling of Caenorhabditis elegans Parkinson's disease models. Journal of Molecular Neuroscience 2010 41 1 210 218 10.1007/s12031-009-9325-1 2-s2.0-77950188650
33. Tranter M., Helsley R. N., Paulding W. R., McGuinness M., Brokamp C., Haar L., Liu Y., Ren X., Jones W. K., Coordinated post-transcriptional regulation of Hsp70.3 gene expression by microRNA and alternative polyadenylation. The Journal of Biological Chemistry 2011 286 34 29828 29837 10.1074/jbc.M111.221796 2-s2.0-80051935631
34. Yin C., Salloum F. N., Kukreja R. C., A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70. Circulation Research 2009 104 5 572 575 10.1161/CIRCRESAHA. 108.193250 2-s2.0-63649126549